HRTX
Heron Therapeuti
0.3559$
+13.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +2,305.6% | +151.8% | +88.4% | -39.3% | -2.6% | +24.7% | +18.0% | +13.6% | +7.4% | |
| – | +11.6% | -99.9% | +13,008.6% | +499.7% | +124.0% | -41.3% | +27.2% | +19.2% | +18.6% | -40.6% | +7.0% | |
| – | – | – | +2,004.4% | +90.8% | +68.8% | -37.8% | -23.1% | +30.9% | +17.3% | +70.6% | +7.5% | |
| – | +11.6% | +68.6% | +34.4% | +1.0% | +19.5% | +4.3% | -25.0% | -17.8% | -63.6% | -57.4% | -25.5% | |
| – | +81.2% | -40.2% | +19.6% | +14.5% | +29.5% | +11.4% | -4.9% | -6.8% | +56.2% | -8.7% | +2.3% | |
| – | +30.0% | +77.6% | +28.2% | +6.0% | +26.1% | -4.9% | -8.0% | -11.9% | -24.1% | -32.1% | -0.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.0% | +178.1% | +47.8% | -32.1% | -44.9% | +29.1% | +26.8% | +2.7% | +56.3% | +55.9% | +59.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +99.3% | -75.9% | -252.1% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.